by CCHR National Affairs Office | Oct 5, 2023
Antipsychotic use by elderly with dementia was also linked to worse outcomes in performing their activities of daily living after home health care ended. A new clinical study has found evidence that powerful antipsychotic drugs are overly prescribed to older...
by CCHR National Affairs Office | Sep 28, 2023
Over 5,000 mistakes were reported to poison centers in 2021, meaning a child was harmed every 100 minutes; not all medication errors are reported. Rising right along with the rapid increase in prescriptions for ADHD drugs in the U.S. is the frequency with which...
by CCHR National Affairs Office | Sep 20, 2023
High potential for abuse and overdose of prescription stimulants prompts U.S. Food and Drug Administration to research alternative treatments. Prescription stimulants commonly prescribed for behavior labeled attention-deficit hyperactivity disorder (ADHD) are promoted...
by CCHR National Affairs Office | Sep 14, 2023
Publication bias contributes to misperception by doctors that antidepressants are safer, more effective than they really are, new study suggests. Psychiatric journals are less likely to publish studies that find antidepressants increase the risk of suicide than...
by CCHR National Affairs Office | Sep 7, 2023
Women taking antidepressants who are, or are planning to become, pregnant can discuss these risks with their physicians. A new study indicates that expectant mothers’ use of antidepressants during pregnancy may negatively affect the brain development of...
